Record Q2 Revenue Beats Guidance as Defense Subcontract Begins Contributing

What happened

Everspin Technologies reported record second‑quarter revenue that exceeded its own guidance range, powered by MRAM product sales and an initial contribution from the new U.S. defense‑related subcontract. The defense revenue marks the first tangible sign that the $40 million Amentum contract is converting from a headline announcement into actual income, directly addressing a central investor question. The magnitude and quality of this defense contribution remain uncertain without full financial statements, particularly whether it stems from milestone acceptances or one‑time items. Encouragingly, the beat suggests early execution on the defense catalyst, but the company still depends on a 90% distributor channel and faces elevated litigation costs that dilute operating leverage. Confirmation of sustainable defense revenue and a ramp in high‑density xSPI MRAM shipments in the second half of 2026 will be critical to validating the stock’s current valuation.

Implication

If Q3 filings show Amentum‑related contract assets and a step‑up in 256Mb xSPI shipments, the stock could re‑rate toward the $27 base case; otherwise, distraction from channel digestion and litigation costs may drive valuation back toward the $15 bear case.

Thesis delta

The Q2 beat modestly strengthens the bull case by proving early defense subcontract monetization, but the core thesis still depends on sustained Amentum milestone conversions and a 2H26 high‑density xSPI mix shift. The rating remains WAIT until auditable defense accounting and product adoption signals materialize in the next two quarterly filings.